EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Implementation and clinical utility of multigene panels for bleeding, platelet, and thrombotic disorders

Radha Ramanan, Andreas Verstraete, Christine Van Laer, Kathleen Freson

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2025.04.026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Radha Ramanan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium; Australian Centre for Blood Diseases, M…. Hauptthemen laut MEDLINE: Thrombosis, Genetic Testing, Blood Platelet Disorders, Hemorrhage. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health, EAHAD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-throughput sequencing, with its capacity to simultaneously sequence large volumes of genomic data, has evolved from a research-focused technology to a clinical tool. This review outlines key steps in the development of a clinical hemostasis and thrombosis genetics service leveraging a multigene panel. We discuss its value across inherited bleeding, platelet, and thrombotic disorders (BPTDs) in the context of published studies utilizing multigene panels for these conditions. Benefits of sequencing include establishing a diagnosis through the simultaneous assessment of multiple candidate genes, exclusion of genocopies, and predictions of phenotype to deliver targeted therapy. The presence of concomitant variants may modify phenotype; however, predictions on disease course from oligogenic modifiers are not yet used to guide patient care or counseling. Limitations in the widespread roll-out of multigene panels for clinical diagnosis of BPTDs exist. These challenges relate to detection of structural variants, variable diagnostic hit rates, and management of incidental findings. Variants of uncertain significance also frustrate diagnostic yield. Family segregation studies, in vitro characterization, and protein modeling aid interpretation of variant pathogenicity. Although multigene panels offer substantial opportunities to improve BPTD diagnostics, their implementation should be guided by appropriate expertise and in conjunction with clinical research to ensure safe and ethical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombosisGenetic TestingBlood Platelet DisordersHemorrhageBlood CoagulationHumansGenetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingPhenotypePredictive Value of TestsHemostasisGenetic VariationMutation

Stichwörter der Autor:innen

bleedinghigh-throughput sequencingmultigene panelplatelet disorderthrombosis

Autor:innen und Institutionen

  • Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia; Department of Human…
  • Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium; Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.
  • Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium; Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health
  • EAHAD
  • Research Foundation Flanders
  • International Society on Thrombosis and Haemostasis
  • KU Leuven
  • Royal College of Pathologists of Australasia
  • RCPA Foundation

Zitieren

APA

Ramanan, R., Verstraete, A., Van Laer, C., & Freson, K. (2025). Implementation and clinical utility of multigene panels for bleeding, platelet, and thrombotic disorders. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.04.026

Vancouver

Ramanan R, Verstraete A, Van Laer C, Freson K. Implementation and clinical utility of multigene panels for bleeding, platelet, and thrombotic disorders. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.04.026

BibTeX
@article{Ramanan2025,
  author = {Ramanan, Radha and Verstraete, Andreas and Van Laer, Christine and Freson, Kathleen},
  title = {Implementation and clinical utility of multigene panels for bleeding, platelet, and thrombotic disorders},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2025.04.026}
}
Kostenlos starten →